Home/HD Immune/Stefan Bartl, PhD

SB

Stefan Bartl, PhD

Founder, Molecular Biologist

Therapeutic Areas

Neurology Neurodegenerative Diseases

HD Immune Pipeline

Drug	Indication	Phase
HD mAb Therapy	Huntington's Disease	Pre-clinical

Leadership Team at HD Immune

Lionel Wightman, PhD

Virologist, Executive (CEO/CFO/COO experience)

View full HD Immune profile